Australia markets closed

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.01-0.20 (-0.94%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 23.69B
Enterprise value 25.33B
Trailing P/E 33.14
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.36
Price/book (mrq)2.46
Enterprise value/revenue 7.96
Enterprise value/EBITDA 28.69

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-28.87%
S&P500 52-week change 325.38%
52-week high 334.18
52-week low 318.44
50-day moving average 322.33
200-day moving average 326.55

Share statistics

Avg vol (3-month) 310.8M
Avg vol (10-day) 314.28M
Shares outstanding 51.12B
Implied shares outstanding 61.12B
Float 8578.42M
% held by insiders 148.55%
% held by institutions 18.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.18
Forward annual dividend yield 40.85%
Trailing annual dividend rate 30.38
Trailing annual dividend yield 31.79%
5-year average dividend yield 40.78
Payout ratio 428.13%
Dividend date 3N/A
Ex-dividend date 413 Oct 2023
Last split factor 21.6:1
Last split date 302 June 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.32%
Operating margin (ttm)5.95%

Management effectiveness

Return on assets (ttm)2.41%
Return on equity (ttm)7.59%

Income statement

Revenue (ttm)3.18B
Revenue per share (ttm)2.88
Quarterly revenue growth (yoy)-39.60%
Gross profit (ttm)N/A
EBITDA 1.1B
Net income avi to common (ttm)709.91M
Diluted EPS (ttm)0.64
Quarterly earnings growth (yoy)-73.70%

Balance sheet

Total cash (mrq)996.96M
Total cash per share (mrq)0.89
Total debt (mrq)2.63B
Total debt/equity (mrq)27.36%
Current ratio (mrq)1.82
Book value per share (mrq)8.61

Cash flow statement

Operating cash flow (ttm)828.33M
Levered free cash flow (ttm)432.21M